# Balamurali K. Ambati , M.D., Ph.D. – FDA Inspection, Apr 4, 2019

Source: https://www.keypedia.com/records/fda_inspections/balamurali-k-ambati-md-phd/2d9afe58-a72b-4780-9631-b2448f259b9d
Source feed: FDA_Inspections

> FDA inspection 1085546 of Balamurali K. Ambati , M.D., Ph.D., April 04, 2019. Classification: Official Action Indicated (OAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1085546
- Company Name: Balamurali K. Ambati , M.D., Ph.D.
- Inspection Date: 2019-04-04
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1
- Enforcement Type: WARNING_LETTER

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/julian-c-hanson/489e27d9-0de6-4bf0-8aec-e5d500841f52)

Company: https://www.keypedia.com/companies/balamurali-k-ambati-md-phd/a6167b4b-86cb-400e-9cf2-39d29f4bffd7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c